Literature DB >> 27170658

Chronic anemic hypoxemia increases plasma glucagon and hepatic PCK1 mRNA in late-gestation fetal sheep.

Christine Culpepper1, Stephanie R Wesolowski2, Joshua Benjamin1, Jennifer L Bruce1, Laura D Brown2, Sonnet S Jonker3, Randall B Wilkening1, William W Hay1, Paul J Rozance4.   

Abstract

Hepatic glucose production (HGP) normally begins just prior to birth. Prolonged fetal hypoglycemia, intrauterine growth restriction, and acute hypoxemia produce an early activation of fetal HGP. To test the hypothesis that prolonged hypoxemia increases factors which regulate HGP, studies were performed in fetuses that were bled to anemic conditions (anemic: n = 11) for 8.9 ± 0.4 days and compared with control fetuses (n = 7). Fetal arterial hematocrit and oxygen content were 32% and 50% lower, respectively, in anemic vs. controls (P < 0.005). Arterial plasma glucose was 15% higher in the anemic group (P < 0.05). Hepatic mRNA expression of phosphonenolpyruvate carboxykinase (PCK1) was twofold higher in the anemic group (P < 0.05). Arterial plasma glucagon concentrations were 70% higher in anemic fetuses compared with controls (P < 0.05), and they were positively associated with hepatic PCK1 mRNA expression (P < 0.05). Arterial plasma cortisol concentrations increased 90% in the anemic fetuses (P < 0.05), but fetal cortisol concentrations were not correlated with hepatic PCK1 mRNA expression. Hepatic glycogen content was 30% lower in anemic vs. control fetuses (P < 0.05) and was inversely correlated with fetal arterial plasma glucagon concentrations. In isolated primary fetal sheep hepatocytes, incubation in low oxygen (3%) increased PCK1 mRNA threefold compared with incubation in normal oxygen (21%). Together, these results demonstrate that glucagon and PCK1 may potentiate fetal HGP during chronic fetal anemic hypoxemia.
Copyright © 2016 the American Physiological Society.

Entities:  

Keywords:  PEPCK; glucose; glycogen; hepatocyte; oxygen

Mesh:

Substances:

Year:  2016        PMID: 27170658      PMCID: PMC4967231          DOI: 10.1152/ajpregu.00037.2016

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  52 in total

1.  Increased insulin sensitivity and maintenance of glucose utilization rates in fetal sheep with placental insufficiency and intrauterine growth restriction.

Authors:  Sean W Limesand; Paul J Rozance; Danielle Smith; William W Hay
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-09-25       Impact factor: 4.310

2.  Attenuated insulin release and storage in fetal sheep pancreatic islets with intrauterine growth restriction.

Authors:  Sean W Limesand; Paul J Rozance; Gary O Zerbe; John C Hutton; William W Hay
Journal:  Endocrinology       Date:  2005-12-08       Impact factor: 4.736

Review 3.  The intrauterine growth restriction phenotype: fetal adaptations and potential implications for later life insulin resistance and diabetes.

Authors:  Stephanie R Thorn; Paul J Rozance; Laura D Brown; William W Hay
Journal:  Semin Reprod Med       Date:  2011-06-27       Impact factor: 1.303

4.  Transfusion effects on cardiomyocyte growth and proliferation in fetal sheep after chronic anemia.

Authors:  Sonnet S Jonker; Thomas D Scholz; Jeffrey L Segar
Journal:  Pediatr Res       Date:  2011-06       Impact factor: 3.756

Review 5.  Regulation of hypoxia-inducible genes by PGC-1 alpha.

Authors:  Jonathan Shoag; Zolt Arany
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-11-30       Impact factor: 8.311

6.  Increased amino acid supply potentiates glucose-stimulated insulin secretion but does not increase β-cell mass in fetal sheep.

Authors:  Monika M Gadhia; Anne M Maliszewski; Meghan C O'Meara; Stephanie R Thorn; Jinny R Lavezzi; Sean W Limesand; William W Hay; Laura D Brown; Paul J Rozance
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-12-04       Impact factor: 4.310

7.  Limited capacity for glucose oxidation in fetal sheep with intrauterine growth restriction.

Authors:  Laura D Brown; Paul J Rozance; Jennifer L Bruce; Jacob E Friedman; William W Hay; Stephanie R Wesolowski
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-07-29       Impact factor: 3.619

Review 8.  Sheep models of intrauterine growth restriction: fetal adaptations and consequences.

Authors:  Janna L Morrison
Journal:  Clin Exp Pharmacol Physiol       Date:  2008-07       Impact factor: 2.557

9.  Impaired oxidative phosphorylation in hepatic mitochondria in growth-retarded rats.

Authors:  Iyalla E Peterside; Mary A Selak; Rebecca A Simmons
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-12       Impact factor: 4.310

Review 10.  Transcriptional regulation by hypoxia inducible factors.

Authors:  Veronica L Dengler; Matthew Galbraith; Joaquín M Espinosa
Journal:  Crit Rev Biochem Mol Biol       Date:  2013-10-07       Impact factor: 8.250

View more
  14 in total

1.  Sustained hypoxemia in late gestation potentiates hepatic gluconeogenic gene expression but does not activate glucose production in the ovine fetus.

Authors:  Amanda K Jones; Paul J Rozance; Laura D Brown; David A Goldstrohm; William W Hay; Sean W Limesand; Stephanie R Wesolowski
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-04-09       Impact factor: 4.310

2.  A Chronic Fetal Leucine Infusion Potentiates Fetal Insulin Secretion and Increases Pancreatic Islet Size, Vascularity, and β Cells in Late-Gestation Sheep.

Authors:  Brit H Boehmer; Laura D Brown; Stephanie R Wesolowski; William W Hay; Paul J Rozance
Journal:  J Nutr       Date:  2020-08-01       Impact factor: 4.798

3.  Chronic anemic hypoxemia attenuates glucose-stimulated insulin secretion in fetal sheep.

Authors:  Joshua S Benjamin; Christine B Culpepper; Laura D Brown; Stephanie R Wesolowski; Sonnet S Jonker; Melissa A Davis; Sean W Limesand; Randall B Wilkening; William W Hay; Paul J Rozance
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-01-18       Impact factor: 3.619

4.  Exogenous amino acids suppress glucose oxidation and potentiate hepatic glucose production in late gestation fetal sheep.

Authors:  Laura D Brown; Jaden R Kohn; Paul J Rozance; William W Hay; Stephanie R Wesolowski
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-02-08       Impact factor: 3.619

5.  IUGR impairs cardiomyocyte growth and maturation in fetal sheep.

Authors:  Sonnet S Jonker; Daniel Kamna; Dan LoTurco; Jenai Kailey; Laura D Brown
Journal:  J Endocrinol       Date:  2018-10-16       Impact factor: 4.286

6.  Effects of chronic hyperinsulinemia on metabolic pathways and insulin signaling in the fetal liver.

Authors:  Paul J Rozance; Amanda K Jones; Stephanie L Bourque; Angelo D'Alessandro; William W Hay; Laura D Brown; Stephanie R Wesolowski
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-08-24       Impact factor: 4.310

7.  Leucine acutely potentiates glucose-stimulated insulin secretion in fetal sheep.

Authors:  Brit H Boehmer; Peter R Baker; Laura D Brown; Stephanie R Wesolowski; Paul J Rozance
Journal:  J Endocrinol       Date:  2020-10       Impact factor: 4.286

8.  Chorionic somatomammotropin RNA interference alters fetal liver glucose utilization.

Authors:  Asghar Ali; Callie M Swanepoel; Quinton A Winger; Paul J Rozance; Russell V Anthony
Journal:  J Endocrinol       Date:  2020-12       Impact factor: 4.286

9.  Augmented glucose production is not contingent on high catecholamines in fetal sheep with IUGR.

Authors:  Melissa A Davis; Leticia E Camacho; Alexander L Pendleton; Andrew T Antolic; Rosa I Luna-Ramirez; Amy C Kelly; Nathan R Steffens; Miranda J Anderson; Sean W Limesand
Journal:  J Endocrinol       Date:  2021-05-13       Impact factor: 4.286

10.  Reduced glucose-stimulated insulin secretion following a 1-wk IGF-1 infusion in late gestation fetal sheep is due to an intrinsic islet defect.

Authors:  Alicia White; Jane Stremming; Brit H Boehmer; Eileen I Chang; Sonnet S Jonker; Stephanie R Wesolowski; Laura D Brown; Paul J Rozance
Journal:  Am J Physiol Endocrinol Metab       Date:  2021-05-03       Impact factor: 5.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.